You are here

THE MEASUREMENT OF GLYCOSYLATED HEMOGLOBIN IS PROBABLY THE BEST MEANS OF ASSESSING GLUCOSE CONTROL OVER TIME IN DIABETICS.

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: N/A
Agency Tracking Number: 1375
Amount: $48,741.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: N/A
Timeline
Solicitation Year: N/A
Award Year: 1984
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
4690 Hammermill Road
Atlanta, GA 30084
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 DANIEL B. CAWLEY
 RESEARCH SCIENTIST
 () -
Business Contact
Phone: () -
Research Institution
N/A
Abstract

THE MEASUREMENT OF GLYCOSYLATED HEMOGLOBIN IS PROBABLY THE BEST MEANS OF ASSESSING GLUCOSE CONTROL OVER TIME IN DIABETICS. IT NOW APPEARS THERE IS INVERSE CORRELATION BETWEEN THE CONTROL OF GLUCOSE METABOLISM AND COMPLICATIONS OF THE DISEASE IN THAT WELL CONTROLLED DIABETICS DO MUCH BETTER. THE CURRENTLY AVAILABLE ASSAY SYSTEMS FOR QUANTITATING GLYCOSYLATED HEMOGLOBIN ARE BULKY, TIME CONSUMING AND EXPENSIVE AND THEREFORE ARE IDEAL CANDIDATES FOR REPLACEMENT WITH A MONOCLONAL ANTIBODY BASED IMMUNOASSAY. TO THAT END ANTIBODIES FROM HYBRIDOMA CLONES DERIVED FROM FUSIONS OF SPLEEN CELLS FROM MICE IMMUNIZED WITH THE GLYCOSYLATED HEMOGLOBIN ARE CURRENTLY BEING EVALUATED AND PLANS ARE TO DEVELOP ADDITIONAL HYBRIDOMAS AS PART OF PHASE I. DURING PHASE II A TWO-SITE IMMUNOMETRIC ASSAY WILL BE DEVELOPED FOR QUANTITATION OF GLYCOSYLATED HEMOGLOBIN FOR USE IN THE CLINICAL LABORATORY.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government